Novel H1N1 (referred to as “swine flu” early on) is a new influenza virus causing illness in people. This new virus was first detected in people in the United States in April 2009. Other countries, including Mexico and Canada, have reported people sick with this new virus. This virus is spreading from person-to-person, probably in much the same way that regular seasonal influenza viruses spread.
Each year, seasonal flu kills approximately 36,000 people in the United States, most over age 70.Yet little is known about the benefit of influenza vaccine in older seniors.
Scientists at St. Jude Children’s Research Hospital have found key features that distinguish influenza viruses found in birds from those that infect humans.
Very low doses of Novavax Inc.’s pandemic influenza vaccine provided protection against a lethal challenge of live H5N1 viruses, according to pre-clinical data presented here today at the Second International Conference on Avian Influenza in Humans.
Regular as clockwork, the flu arrives every year. And, according to the national Centers for Disease Control and Prevention, 5 to 20 percent of the U.S. population on average will come down with it. About 36,000 people will die.
An experimental flu vaccine made in insect cells ? not in eggs, where flu vaccines currently available in the United States are grown ? is safe and as effective as conventional vaccines in protecting people against the flu, according to results published in the April 11 issue of the Journal of the American Medical Association.
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced it is awarding $23 million per year for seven years to establish six Centers of Excellence for Influenza Research and Surveillance.
The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), announced today that it has achieved a major milestone.
The UK Department of Health has announced that free seasonal flu vaccinations will be offered to people who work in close contact with poultry, as a precautionary public health measure.
Researchers at the University of Maryland School of Medicine in Baltimore will begin a clinical trial in January to test the first cell culture-based pandemic influenza vaccine to see if it will provide immunity faster and more reliably than a vaccine produced in eggs. The new study is also the first test in the United States of a whole virus vaccine for avian influenza, which could produce a stronger response by the immune system.